CHF 978.56
(0.57%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 525 Million CHF | -11.02% |
2022 | 590 Million CHF | 5.36% |
2021 | 560 Million CHF | 48.35% |
2020 | 377.49 Million CHF | 47.47% |
2019 | 255.98 Million CHF | 132.71% |
2018 | 110 Million CHF | 10.0% |
2017 | 100 Million CHF | 9.76% |
2016 | 91.1 Million CHF | -57.56% |
2015 | 214.66 Million CHF | 89.57% |
2014 | 113.24 Million CHF | 89.68% |
2013 | 59.7 Million CHF | 57.06% |
2012 | 38.01 Million CHF | 0.0% |
2011 | - CHF | 0.0% |
2010 | - CHF | 0.0% |
2009 | - CHF | -100.0% |
2008 | 86.12 Million CHF | 13.59% |
2007 | 75.82 Million CHF | -33.51% |
2006 | 114.03 Million CHF | 0.0% |
2005 | - CHF | 0.0% |
2004 | - CHF | 0.0% |
2003 | - CHF | 0.0% |
2002 | - CHF | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 430 Million CHF | 0.0% |
2023 Q2 | 550 Million CHF | 0.0% |
2023 Q4 | 525 Million CHF | 0.0% |
2023 FY | 525 Million CHF | -11.02% |
2022 Q4 | 590 Million CHF | 0.0% |
2022 FY | 590 Million CHF | 5.36% |
2022 Q2 | 530 Million CHF | 0.0% |
2021 Q2 | 497.53 Million CHF | 0.0% |
2021 Q4 | 560 Million CHF | 0.0% |
2021 FY | 560 Million CHF | 48.35% |
2020 Q4 | 377.49 Million CHF | 0.0% |
2020 FY | 377.49 Million CHF | 47.47% |
2020 Q2 | 389.98 Million CHF | 0.0% |
2019 Q4 | 255.98 Million CHF | 0.0% |
2019 FY | 255.98 Million CHF | 132.71% |
2019 Q2 | 340.98 Million CHF | 0.0% |
2018 Q4 | 110 Million CHF | 0.0% |
2018 FY | 110 Million CHF | 10.0% |
2018 Q2 | 80 Million CHF | 0.0% |
2017 Q2 | 100 Million CHF | 0.0% |
2017 Q4 | 100 Million CHF | 0.0% |
2017 FY | 100 Million CHF | 9.76% |
2016 Q2 | 225.5 Million CHF | 0.0% |
2016 Q4 | 91.1 Million CHF | 0.0% |
2016 FY | 91.1 Million CHF | -57.56% |
2015 Q2 | 145.07 Million CHF | 0.0% |
2015 Q4 | 214.66 Million CHF | 0.0% |
2015 FY | 214.66 Million CHF | 89.57% |
2014 Q4 | 113.24 Million CHF | 0.0% |
2014 FY | 113.24 Million CHF | 89.68% |
2014 Q2 | 58.64 Million CHF | 0.0% |
2013 Q2 | 43.58 Million CHF | 0.0% |
2013 Q4 | 59.7 Million CHF | 0.0% |
2013 FY | 59.7 Million CHF | 57.06% |
2012 Q2 | - CHF | 0.0% |
2012 FY | 38.01 Million CHF | 0.0% |
2012 Q4 | 38.01 Million CHF | 0.0% |
2011 Q2 | - CHF | 0.0% |
2011 Q4 | - CHF | 0.0% |
2011 FY | - CHF | 0.0% |
2010 Q2 | - CHF | 0.0% |
2010 Q4 | - CHF | 0.0% |
2010 FY | - CHF | 0.0% |
2009 Q4 | - CHF | 0.0% |
2009 FY | - CHF | -100.0% |
2008 FY | 86.12 Million CHF | 13.59% |
2007 FY | 75.82 Million CHF | -33.51% |
2006 FY | 114.03 Million CHF | 0.0% |
2005 FY | - CHF | 0.0% |
2004 FY | - CHF | 0.0% |
2003 FY | - CHF | 0.0% |
2002 FY | - CHF | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Relief Therapeutics Holding AG | 9000.00 CHF | -5833233.333% |
Tecan Group AG | 303.85 Million CHF | -72.78% |
Santhera Pharmaceuticals Holding AG | 1.47 Million CHF | -35420.974% |
Basilea Pharmaceutica AG | 95.45 Million CHF | -449.997% |
Bachem Holding AG | 218 Thousand CHF | -240725.688% |
Molecular Partners AG | 2.44 Million CHF | -21381.178% |